Monsanto Co. (MON) to Release Quarterly Earnings on Wednesday
Monsanto Co. (NYSE:MON) will be announcing its Q416 earnings results on Wednesday, October 5th. Analysts expect the company to announce earnings of ($0.02) per share and revenue of $2.38 billion for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.
Shares of Monsanto Co. (NYSE:MON) opened at 102.47 on Tuesday. Monsanto Co. has a 52-week low of $83.73 and a 52-week high of $114.26. The stock has a market cap of $44.84 billion, a price-to-earnings ratio of 45.10 and a beta of 1.19. The stock’s 50 day moving average price is $105.05 and its 200-day moving average price is $101.24.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be paid a $0.54 dividend. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.11%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s dividend payout ratio is presently 89.26%.
A number of equities analysts have recently commented on the stock. Goldman Sachs Group Inc. raised shares of Monsanto from a “sell” rating to a “neutral” rating and set a $104.00 target price on the stock in a research note on Tuesday, September 27th. Jefferies Group reissued a “buy” rating on shares of Monsanto in a research note on Wednesday, June 29th. Piper Jaffray Cos. set a $128.00 target price on shares of Monsanto and gave the company a “buy” rating in a research note on Thursday, September 15th. Citigroup Inc. reissued a “neutral” rating and issued a $112.00 target price (up previously from $94.00) on shares of Monsanto in a research note on Friday, July 1st. Finally, Zacks Investment Research raised shares of Monsanto from a “sell” rating to a “hold” rating in a research note on Wednesday, June 8th. Two analysts have rated the stock with a sell rating, nine have given a hold rating, fifteen have assigned a buy rating and one has given a strong buy rating to the company. Monsanto has an average rating of “Buy” and a consensus target price of $114.21.
In other news, COO Brett D. Begemann sold 27,980 shares of the stock in a transaction that occurred on Thursday, July 14th. The shares were sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the transaction, the chief operating officer now directly owns 102,480 shares in the company, valued at $10,618,977.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Michael K. Stern sold 12,797 shares of the stock in a transaction that occurred on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the completion of the transaction, the chief executive officer now owns 21,583 shares of the company’s stock, valued at $2,196,501.91. The disclosure for this sale can be found here. 0.88% of the stock is currently owned by insiders.
Hedge funds and other institutional investors have recently bought and sold shares of the stock. FMR LLC boosted its stake in shares of Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock worth $1,715,960,000 after buying an additional 4,851,499 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its stake in shares of Monsanto by 0.3% in the second quarter. Massachusetts Financial Services Co. MA now owns 14,893,956 shares of the company’s stock worth $1,540,185,000 after buying an additional 38,316 shares during the last quarter. Capital International Investors boosted its stake in shares of Monsanto by 6.2% in the second quarter. Capital International Investors now owns 8,187,701 shares of the company’s stock worth $846,690,000 after buying an additional 476,848 shares during the last quarter. TIAA CREF Investment Management LLC boosted its stake in shares of Monsanto by 50.4% in the second quarter. TIAA CREF Investment Management LLC now owns 4,658,464 shares of the company’s stock worth $481,732,000 after buying an additional 1,560,646 shares during the last quarter. Finally, Third Point LLC acquired a new stake in shares of Monsanto during the second quarter worth $206,820,000. Institutional investors and hedge funds own 79.02% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.